Status:

UNKNOWN

Reflux Disease After Gastric Bypass Versus Sleeve Gastrectomy in Morbid Obese Patients: an Italian Study

Lead Sponsor:

Niguarda Hospital

Conditions:

Gastroesophageal Reflux Disease

Obesity

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

The study aims to clarify if GERD, defined by results of 24 hours potential of hydrogen (pH) monitoring and abnormal DeMeester Score (DMS), in obese patients could worsen after Sleeve Gastrectomy (SG)...

Detailed Description

Obesity is an independent risk factor for GERD and its complications. Bariatric surgery is effective in treatment of obesity and at the same time in controlling GERD, but there is disparity in current...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Acceptance of randomization to surgery;
  • Participant is willing and able to give informed consent for participation in the trial;
  • Written informed consent;
  • Compliance to follow-up;
  • Male and female;
  • ≥18 and ≤70 years old;
  • BMI ≥ 35 with obesity-related comorbidities;
  • BMI ≥ 40 with or without obesity-related comorbidities;
  • GERDQ score ≥ 3 points;
  • Use of proton pump inhibitor;
  • Mild and Moderate GERD (DMS ≥14.72 ≤100)
  • Incompetence of the Esophagogastric junction
  • Los Angeles grade A, B, C, D esophagitis.
  • Exclusion criteria
  • Medical or psychiatric conditions that compromises the patient's ability to give informed consent or comply with the study protocol;
  • Barrett's esophagus (BE);
  • Spastic motor disorders and esophageal hypomotility;
  • Peptic strictures;
  • Absence of GERD (DMS\<14.72);
  • Severe GERD (DMS\>100);
  • Hiatal hernia \> 5 cm;
  • Previous bariatric surgery or major general surgery;
  • Type 2 diabetes (T2D) for more than \> 5 years;
  • Necessity to explore stomach, the duodenum or the biliary tract;
  • Refuse of randomization;
  • Personal reasons.

Exclusion

    Key Trial Info

    Start Date :

    May 1 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    May 1 2025

    Estimated Enrollment :

    128 Patients enrolled

    Trial Details

    Trial ID

    NCT04763993

    Start Date

    May 1 2024

    End Date

    May 1 2025

    Last Update

    March 22 2023

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.